ascopubs.org6d
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...
ascopubs.org2d
ABCA1 and ABCG1 cholesterol transporters expression on metastatic renal cell carcinoma: Impact on immunotherapy outcomes (CHOMET study).
Association between abnormal IMDC laboratory criteria after surgery and cancer-specific and overall survival in non-metastatic renal cell carcinoma: Potential biomarkers for adjuvant therapy patient ...
ascopubs.org2d
Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.
Serum biomarkers in metastatic castration-resistant prostate cancer (mCRPC) patients receiving [177Lu]Lu-PSMA-617 therapy: Post hoc analysis of a phase II clinical trial. Individual patient data (IPD) ...
ascopubs.org6d
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions In 467 consecutive patients with ALL (0-20 years), we ...
ascopubs.org3d
Improving prostate cancer risk stratification using spatial single-cell tumor profiling.
Application of canary histology classifier in prostate biopsies for risk stratification. Decipher genomic classifier (DGC) of early prostate cancer (EPC), and underlying transcriptomic profile (TP): ...